[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Psoriatic Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs), Immunosuppressants, Biologic Agents, Others), By Route of Administration (Oral, Parenteral, Others), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: P1BE1FBC87BCEN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Psoriatic Arthritis Therapeutics market size is poised to register 9.98% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Psoriatic Arthritis Therapeutics market By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs), Immunosuppressants, Biologic Agents, Others), By Route of Administration (Oral, Parenteral, Others).

Psoriatic arthritis (PsA) is a chronic inflammatory joint disease that affects individuals with psoriasis, causing joint pain, stiffness, and swelling, often leading to disability and impaired quality of life. Key trends in PsA therapeutics include the development of biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) that inhibit specific cytokines and immune pathways involved in the pathogenesis of PsA, such as TNF inhibitors, IL-17 inhibitors, and JAK inhibitors, offering improved control of joint inflammation and prevention of structural damage. Additionally, there's growing interest in combination therapies incorporating DMARDs with different mechanisms of action, such as TNF inhibitors with methotrexate or conventional synthetic DMARDs, for their synergistic effects and enhanced efficacy in PsA management. Moreover, advancements in imaging techniques, including magnetic resonance imaging (MRI) and ultrasound, are facilitating early diagnosis and monitoring of PsA disease activity, enabling timely intervention and personalized treatment approaches for patients with PsA..

Psoriatic Arthritis Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Psoriatic Arthritis Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Psoriatic Arthritis Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Psoriatic Arthritis Therapeutics industry.

Key market trends defining the global Psoriatic Arthritis Therapeutics demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Psoriatic Arthritis Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Psoriatic Arthritis Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Psoriatic Arthritis Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Psoriatic Arthritis Therapeutics industry

Leading Psoriatic Arthritis Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Psoriatic Arthritis Therapeutics companies.

Psoriatic Arthritis Therapeutics Market Study- Strategic Analysis Review

The Psoriatic Arthritis Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Psoriatic Arthritis Therapeutics Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Psoriatic Arthritis Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Psoriatic Arthritis Therapeutics Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Psoriatic Arthritis Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Psoriatic Arthritis Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Psoriatic Arthritis Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Psoriatic Arthritis Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Psoriatic Arthritis Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Psoriatic Arthritis Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Psoriatic Arthritis Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Psoriatic Arthritis Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Psoriatic Arthritis Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Psoriatic Arthritis Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Psoriatic Arthritis Therapeutics Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Psoriatic Arthritis Therapeutics Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Psoriatic Arthritis Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Psoriatic Arthritis Therapeutics.

Psoriatic Arthritis Therapeutics Market Company Profiles

The global Psoriatic Arthritis Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Celgene Corp, Eisai Inc, Johnson & Johnson, Otsuka Pharmaceutical, Pfizer Inc, Sanofi S.A., Sumitomo Dainippon Pharma Co, UCB SA.

Recent Psoriatic Arthritis Therapeutics Market Developments

The global Psoriatic Arthritis Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Psoriatic Arthritis Therapeutics Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Type

Stationary 3D and 4D Ultrasound Devices

Portable 3D and 4D Ultrasound Devices

By Display

Color Ultrasound

B/W Ultrasound

By Portability

Trolley or Cart-Based Ultrasound Systems

Compact/Handheld Ultrasound Systems

Point-of-Pare (PoC) Ultrasound Systems

By Application

Radiology or General Imaging

Obstetrics or Gynecology

Cardiology

Urology

Vascular

Orthopedic and Musculoskeletal

Pain Management

Others

By End-User

Hospitals

Surgical Centers and Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Research and Academia

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

AbbVie Inc

Celgene Corp

Eisai Inc

Johnson & Johnson

Otsuka Pharmaceutical

Pfizer Inc

Sanofi S.A.

Sumitomo Dainippon Pharma Co

UCB SA

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Psoriatic Arthritis Therapeutics Market Overview and Key Findings, 2024
1.2 Psoriatic Arthritis Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Psoriatic Arthritis Therapeutics Market Growth Opportunities to 2030
1.4 Key Psoriatic Arthritis Therapeutics Market Trends and Challenges
  1.4.1 Psoriatic Arthritis Therapeutics Market Drivers and Trends
  1.4.2 Psoriatic Arthritis Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Psoriatic Arthritis Therapeutics Companies

2. PSORIATIC ARTHRITIS THERAPEUTICS MARKET SIZE OUTLOOK TO 2030

2.1 Psoriatic Arthritis Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Psoriatic Arthritis Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. PSORIATIC ARTHRITIS THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. PSORIATIC ARTHRITIS THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Psoriatic Arthritis Therapeutics Market, 2025
5.2 Asia Pacific Psoriatic Arthritis Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Psoriatic Arthritis Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Psoriatic Arthritis Therapeutics Market, 2025
5.5 Europe Psoriatic Arthritis Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Psoriatic Arthritis Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Psoriatic Arthritis Therapeutics Market, 2025
5.8 North America Psoriatic Arthritis Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Psoriatic Arthritis Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Psoriatic Arthritis Therapeutics Market, 2025
5.11 South America Pacific Psoriatic Arthritis Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Psoriatic Arthritis Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Psoriatic Arthritis Therapeutics Market, 2025
5.14 Middle East Africa Psoriatic Arthritis Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Psoriatic Arthritis Therapeutics Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Psoriatic Arthritis Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Psoriatic Arthritis Therapeutics Industry Drivers and Opportunities

7. PSORIATIC ARTHRITIS THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. PSORIATIC ARTHRITIS THERAPEUTICS COMPANY PROFILES

8.1 Profiles of Leading Psoriatic Arthritis Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Celgene Corp
Eisai Inc
Johnson & Johnson
Otsuka Pharmaceutical
Pfizer Inc
Sanofi S.A.
Sumitomo Dainippon Pharma Co
UCB SA

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications